Lymphangioleiomyomatosis: current understanding and potential treatments
LM Moir - Pharmacology & therapeutics, 2016 - Elsevier
Lymphangioleiomyomatosis (LAM) is a rare neoplastic disease affecting predominantly
young women. Clinical symptoms of this progressive disease include dyspnoea, cough …
young women. Clinical symptoms of this progressive disease include dyspnoea, cough …
Diagnosis and treatment of lymphangioleiomyomatosis (LAM) from the PEComa group
A Sobiborowicz, AM Czarnecka… - Oncology in Clinical …, 2021 - journals.viamedica.pl
Lymphangioleiomyomatosis (LAM) is a rare, proliferative lung disease, leading to
progressive damage of their structure and is a member of the PEComa neoplasm family …
progressive damage of their structure and is a member of the PEComa neoplasm family …
Rozpoznanie i leczenie limfangioleiomiomatozy (LAM) z grupy PEComa
A Sobiborowicz, AM Czarnecka… - Onkologia w …, 2021 - journals.viamedica.pl
Naczyniakowatość limfatyczna (limfangioleiomiomatoza; LAM) to rzadka rozrostowa
choroba płuc, prowadząca do postępującego uszkodzenia ich struktury, zaliczana do …
choroba płuc, prowadząca do postępującego uszkodzenia ich struktury, zaliczana do …